CLINICAL_TRIALS
safety_alert
· 2017-10-18
Clinical Trial Update: Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis Infection
Summary
This clinical trial update discusses adverse drug reactions observed with anti-tuberculosis drugs used to treat latent tuberculosis infection.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hanyang University | Conditions: Latent Tuberculosis Infection | Status: UNKNOWN